Pfizer Announces Executive Leadership to Advance Oncology Research and Development Strategy
Go back to Pfizer Announces Executive Leadership to Advance Oncology Research and Development Strategy| Pfizer Inc. (NYSE: PFE) | Delayed: 26.80 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.80 | 52 Week High | $37.39 | |||
| Open | $26.80 | 52 Week Low | $28.25 | |||
| Day High | $26.80 | P/E | 16.24 | |||
| Day Low | $26.80 | EPS | $1.65 | |||
| Volume | 28,252 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 26.80 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.80 | 52 Week High | $37.39 | |||
| Open | $26.80 | 52 Week Low | $28.25 | |||
| Day High | $26.80 | P/E | 16.24 | |||
| Day Low | $26.80 | EPS | $1.65 | |||
| Volume | 28,252 | |||||
